The drugmaker has significantly scaled up its manufacturing capacity in 2021. It shipped 18 million doses to the U.S. in January, 26 million doses in February and 44 million doses in March. Going forward, Moderna expects to ship 40 million to 50 million doses to the U.S. government per month.
The U.S. has bought 300 million doses of Moderna’s COVID-19 vaccine. The drugmaker plans to ship the second 100 million doses by the end of May and the third 100 million doses by the end of July.
More articles on pharmacy:
AstraZeneca’s COVID-19 vaccine’s woes: a timeline
Dr. Slaoui leaves 2 more drugmakers, apologizes amid sexual harassment allegations
US commits $10B to vaccine confidence, access efforts
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
